Coach — Reproductive / Infertility: Mitochondrial Engine of Gametes
Infertility is usually explained through hormone levels, semen reports, embryo genetics, and the next stimulation cycle. The working hypothesis here starts one layer upstream. Eggs, sperm, the cells that support them, and the lining of the uterus are among the most energy-expensive tissues in human biology, and when their mitochondria fall short, the problems the reports describe begin to appear.
Safety before ideas
This essay does not replace reproductive endocrinology, urology, or obstetrics. The extended report puts its cautions first: "Ectopic pregnancy, ovarian hyperstimulation, testicular torsion, acute pelvic infection, severe anemia in pregnancy, and threatened miscarriage clocks belong in urgent clinical care. Do not stop fertility drugs, anticoagulants, thyroid replacement, insulin, or immunosuppressants from this page." It sets limits on its own claims too: "Hypothesis language is not a promise that infertility, oocyte quality, sperm DNA fragmentation, or miscarriage risk will reverse."
A few practical cautions follow. An AMH level, an FSH level, or an embryo genetics report is neither proof that anything has been repaired nor proof that energy is irrelevant. No peptide, hormone, or GLP-1 fertility protocol is offered here, and no dosing of any kind, including for NAD+ precursors, stimulation, or luteal support. Antioxidant programs are not a first step ahead of food, light, sleep, and strength. Decisions about stimulation, insemination, IVF, ICSI, embryo testing, donor gametes, and the timing of any cycle belong with the treating physicians, who also know the calendar a person is working against.
Infertility is never a personal failing. It is hard, often painful biology, and the people living through it deserve care and patience, not blame.
What conventional care sees
Infertility affects roughly one in six couples worldwide. Conventional care sorts causes into ovulatory disorders, tubal factors, uterine problems, male-factor semen defects, diminished ovarian reserve, and a large remainder labeled unexplained. Its tools, from ovulation induction through insemination to IVF and ICSI with or without genetic testing, have enabled many births, and the report respects their grounding and their usefulness.
The report's concern is what the model leaves open. Unexplained infertility remains a large share of cases. As maternal age rises, egg quality, more than egg number, becomes a major limit on IVF success, and embryos carry more chromosome errors with age despite laboratory advances. Sperm DNA fragmentation and poor motility can persist without an identified cause. Obesity worsens fertility and assisted-reproduction outcomes in a dose-dependent way, in women and in men as well, and insulin resistance, type 2 diabetes, and metabolic syndrome are likely to act similarly. And early miscarriage rates remain higher even after a chromosomally normal embryo is transferred in women with obesity.
One layer upstream
The report proposes that many forms of infertility, particularly age-related, metabolic, and unexplained ones, begin as an energy crisis inside reproductive cells. Eggs carry only the mother's mitochondria, which must power maturation, fertilization, and the first cell divisions until the embryo's own genes switch on. Falling NAD+ levels, weaker mitochondrial function, and oxidative injury to the spindle that separates chromosomes are linked, largely in animal studies, to the spindle errors, chromosome misalignment, and reduced competence typical of older and metabolically stressed eggs; whether aging eggs accumulate mitochondrial DNA mutations is disputed.
In sperm, a sheath of mitochondria in the midpiece powers swimming. When it falters, motility may fall, and its reactive oxygen can damage sperm; high DNA fragmentation indices are linked to miscarriage. The supporting cells matter as well: the cells that make sex steroids, the granulosa cells that nurture follicles, the Sertoli cells that nurture sperm, and the uterine lining, whose energy shapes implantation, vessel remodeling, and immune tolerance of the embryo.
In this model, body-wide conditions amplify the shortfall: high insulin, inactivity, disrupted circadian rhythms, and diets high in refined carbohydrate but short on mitochondrial cofactors. In this view, hormone changes such as higher androgens in PCOS, and inflammatory signals, often amplify a problem the energy deficit set in motion. The report is explicit that "Naming hormones as amplifiers is not authorization to invent HRT or peptide dosing protocols on this page."
Evidence and the NAD+ question
The report cites convergent evidence. Mitochondrial changes are documented in eggs from older women and from women with endometriosis, including fewer copies of mitochondrial DNA, and in mice maternal obesity raises reactive oxygen in eggs. Sperm mitochondrial function tracks motility and DNA fragmentation. In animals, transferring cytoplasm or mitochondria has improved egg competence. Weight loss and exercise improve pregnancy rates and ovulation in some trials, but have not consistently improved births. In mice, studies such as Bertoldo and colleagues in Cell Reports in 2020 and Miao and colleagues in 2020 found that egg NAD+ falls with age and that supplementing the precursor NMN improved spindle assembly and egg yield, showed a trend toward better embryo development, and, at the lower dose tested, improved breeding outcomes. Human trials are only beginning.
The report is careful about what this means in practice. It states that naming NMN and NR as relevant substrates "is not a clinical dosing protocol" and "not a guarantee of live birth." It adds: "When an NAD+ precursor is considered in addition to proper human diet, this hypothesis discusses low-dose IR nicotinic acid (NA); NR/NMN are not the default. Information, not a recommendation. Education only; no dosing." Any question about a supplement during fertility treatment or pregnancy belongs with the treating physician.
Useful measures sit beside the reproductive tests, not in place of them: grip, strength, fitness, lean mass, recovery, sleep timing, daylight, insulin tone, and the trend in body composition. The reproductive readings stay with the specialists: hormone panels, semen analysis including DNA fragmentation when used, follicle counts and imaging, and stimulation and embryo data during treatment. Research measures of oxidative stress in follicular fluid or semen are useful only where available and justified; no home test reveals a "fertility type."
Restoring the engine beside fertility care
The report frames its practical ideas as "hypothesis language, not a home protocol, not clinical dosing schedules, and not peptide/HRT/GLP-1 invention." Fuel means less refined carbohydrate and insulin-driving load, with nutrient-dense whole foods: animal proteins and fats for their cofactors, and fermented foods for metabolic flexibility. Time-restricted eating or ketogenic approaches appear only "where medically appropriate," and not for every candidate. Circadian care means morning outdoor light, consistent sleep, and steady activity, which the report links to mitochondrial cleanup and to the rhythmic pulses of reproductive hormones. Strength means resistance and aerobic training, which drive the signals for building mitochondria in muscle and improve insulin sensitivity, and may support healthy testosterone physiology in men and blood-vessel and uterine-lining function. More on food is in the fuel essay.
The report sees preconception health as a lever worth studying, with potential benefits for the next generation through healthier eggs, sperm, and conditions during pregnancy. It describes that as "population and counseling language, not a rebuke of necessary ART."
Assisted reproduction as a partner
The report heads off two cartoons: that infertility is only hormones and genes, and that assisted reproduction makes mitochondria irrelevant. ICSI can bypass severe motility problems, and embryo genetic testing can screen for aneuploidy, but in the report's view neither can restore the energy competence of eggs, sperm, or the uterine lining, which is why an age and metabolic gradient persists even after transfer of a chromosomally normal embryo. At the same time, it insists that surgery, stimulation, insemination, IVF, ICSI, and embryo testing "retain and often gain value when deployed in a metabolically supported host." Optimized mitochondrial function may improve egg and sperm quality and tolerance of stimulation and pregnancy, which the report labels "hypothesis language, not a guarantee." Anatomic obstruction, severe genetic problems, and age windows raise the stakes for specialist care, and none of this suggests that diet restores AMH on a schedule.
The order of questions is plain. First come acute and specialty problems: signs of ectopic pregnancy, ovarian hyperstimulation, torsion, pelvic infection, male-factor obstruction needing surgery, and time-sensitive age windows. Then the everyday ground of food, light, sleep, and strength, as gathered on the common-ground page. Then capacity is tracked beside whatever panel the reproductive specialist already runs. Stimulation, luteal support, ICSI, embryo testing, and donor decisions stay with the treating physicians.
Two errors to avoid
Two opposite errors are worth naming. One builds a cart of antioxidants or NAD+ supplements, or decides to skip IVF forever, while food, sleep, and strength stay untouched. The other ignores metabolism entirely because the problem has been labeled genetic or unexplained. A quieter error treats "unexplained" as a complete answer when insulin resistance, abdominal fat, sleep disruption, and ultra-processed food were never addressed. Rejecting indicated assisted reproduction, surgery, or stimulation out of ideology, when time or anatomy demand them, is as much a mistake as relying on the laboratory alone.
Limits and related topics
This is a working hypothesis. The report states that it is "Not a randomized-trial verdict that mitochondrial-first strategies outperform guideline reproductive endocrinology, urology, or ART as monotherapy." It "Does not deny true anatomic obstruction, hypogonadotropic hypogonadism, severe genetic lesions, endometriosis as entity, or the clinical utility of stimulation, ICSI, PGT, or donor gametes when indicated." And it keeps the obstetric stakes clear: "Ectopic pregnancy, OHSS, torsion, acute pelvic infection, and obstetric emergencies remain high-stakes; specialty care owns those clocks."
Planning for birth itself is discussed in its own essay, Planning a Birth. For the full argument, read the extended report on reproduction and infertility. The short version is in the lessons. Talk with your own physician before changing medications or supplements.
A working hypothesis, open to correction and revised as new evidence arrives. Last revised October 31, 2026.
See the notice at the top of this page. Working hypothesis, not medical advice.